Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | BAX | Q07812 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16350499 | 0.74 | — | — | |
| SCHEMBL824571 | 0.72 | LTA4H (0.32) | LTA4HTSHRCA4 | |
| SCHEMBL17689257 | 0.72 | ESR2 (0.47) | LTA4HNR1H2BAX | |
| SCHEMBL29112207 | 0.72 | HPGD (0.37) | TSHRALDH1A1 | |
| SCHEMBL16353372 | 0.72 | FURIN (0.32) | — | |
| SCHEMBL26686884 | 0.70 | — | — | |
| SCHEMBL25426237 | 0.69 | SRC (0.48) | TSHRSRCTDP1L3MBTL1CYP2C9 | |
| SCHEMBL29096159 | 0.69 | CA4 (0.32) | LTA4HTSHRCA4 | |
| SCHEMBL98878 | 0.69 | SRC (0.48) | TSHRSRCTDP1L3MBTL1CYP2C9 | |
| SCHEMBL16350501 | 0.69 | GRIN2D (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271249-A | Diazonium transfer reagent and preparation method and application thereof | 中国科学院上海有机化学研究所 | 2024-07-02 | — | — | CN | disclosed |
| EP-3483193-B1 | CURABLE COMPOSITION, METHOD FOR PRODUCING SAME, AND ARTICLE PRODUCED THEREWITH | DAIKIN IND LTD (JP) | 2023-08-23 | — | — | EP | disclosed |
| US-20100173871-A1 | PHOSPHORYLATED DENDRIMERS AS ANTIINFLAMMATORY DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-07-08 | — | — | US | disclosed |
| CN-1166729-C | Cross-linking of polymers and foams thereof | — | 2004-09-15 | — | — | CN | disclosed |
| CN-1098287-C | Thermoset interpolymers and foams | DOW CHEMICAL CO (US) | 2003-01-08 | — | — | CN | disclosed |
| CN-1276801-A | Thermoset interpolymers and foams | DOW CHEMICAL CO (US) | 2000-12-13 | — | — | CN | disclosed |
| CN-1275996-A | Process for coupling alpha-olefin/vinyl aromatic monomer or hindered aliphatic vinyl monomer interpolymers with polyolefin blends | DOW CHEMIAL CO (US) | 2000-12-06 | — | — | CN | disclosed |
| CN-1270609-A | Cross-linking of polymers and foams thereof | DOW CHEMICAL CO (US) | 2000-10-18 | — | — | CN | disclosed |
| US-5039814-A | Chemical intermediates for angiotensin antagonist | MERCK & CO., INC. (US) | 1991-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173871-A1 | PHOSPHORYLATED DENDRIMERS AS ANTIINFLAMMATORY DRUGS | CD14, DUSP3, IRAK3 | LTA4H 1363/4885TSHR 4090/4885CA4 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.